Zhen Zong1, Hui Li2, Zhikun Ning1, Cegui Hu1, Fuxin Tang3, Xiaojian Zhu1, Huakai Tian1, Taicheng Zhou3, He Wang4. 1. Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China. 2. Department of Rheumatology, The First Affiliated Hospital of Nanchang University, Nanchang, China. 3. Department of Gastroenterological Surgery and Hernia Center, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 4. Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract
BACKGROUND: The potential prognostic value of alternative splicing (AS) variants and regulatory splicing factors in gastric carcinogenesis is unclear. We aimed to exploit the aberrant AS signatures and splicing factors involved in gastric cancer (GC) and to determine their prognostic predictive values. METHODS: We performed detailed data acquisition using the Cancer Genome Atlas project and profiled genome-wide AS signatures in a cohort of 190 patients with stomach adenocarcinoma (STAD). Prognostic prediction models and splicing correlation networks were assessed using an integrative bioinformatics analysis approach. RESULTS: We detected 1,308 overall survival (OS)-related AS signatures in 993 genes, most of which were favorable prognostic factors. Six splicing factors have been suggested to be dysregulated in GC, i.e., DHX15, PPP4R2, PRPF38B, RBM9, RBM15, and ILF3. Another notable finding was that most favorable prognosis AS events were positively correlated with expression of splicing factors, while a majority of poor survival prognostic AS genes were negatively associated with the expression of splicing factors. CONCLUSIONS: To our knowledge, the current study provided the first comprehensive profiling of global modifications in the RNA splicing to identify survival associated AS signatures of GC specific genes. Our findings contribute to a better understanding of aberrant AS signatures and splicing factors in STAD, which can potentially be used as prognostic biomarkers and therapeutic targets for GC. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: The potential prognostic value of alternative splicing (AS) variants and regulatory splicing factors in gastric carcinogenesis is unclear. We aimed to exploit the aberrant AS signatures and splicing factors involved in gastric cancer (GC) and to determine their prognostic predictive values. METHODS: We performed detailed data acquisition using the Cancer Genome Atlas project and profiled genome-wide AS signatures in a cohort of 190 patients with stomach adenocarcinoma (STAD). Prognostic prediction models and splicing correlation networks were assessed using an integrative bioinformatics analysis approach. RESULTS: We detected 1,308 overall survival (OS)-related AS signatures in 993 genes, most of which were favorable prognostic factors. Six splicing factors have been suggested to be dysregulated in GC, i.e., DHX15, PPP4R2, PRPF38B, RBM9, RBM15, and ILF3. Another notable finding was that most favorable prognosis AS events were positively correlated with expression of splicing factors, while a majority of poor survival prognostic AS genes were negatively associated with the expression of splicing factors. CONCLUSIONS: To our knowledge, the current study provided the first comprehensive profiling of global modifications in the RNA splicing to identify survival associated AS signatures of GC specific genes. Our findings contribute to a better understanding of aberrant AS signatures and splicing factors in STAD, which can potentially be used as prognostic biomarkers and therapeutic targets for GC. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Alternative splicing (AS); gastric cancer (GC); integrative bioinformatics
Authors: A Krieg; C Mahotka; T Krieg; H Grabsch; W Müller; S Takeno; C V Suschek; M Heydthausen; H E Gabbert; C D Gerharz Journal: Br J Cancer Date: 2002-03-04 Impact factor: 7.640
Authors: Victoria E S Armero; Marie-Pier Tremblay; Andréa Allaire; Simon Boudreault; Camille Martenon-Brodeur; Cyntia Duval; Mathieu Durand; Elvy Lapointe; Philippe Thibault; Maude Tremblay-Létourneau; Jean-Pierre Perreault; Michelle S Scott; Martin Bisaillon Journal: PLoS One Date: 2017-05-11 Impact factor: 3.240